secwatch.observer — SEC 8-K summary
======================================

Issuer:     PTC THERAPEUTICS, INC. (PTCT)
CIK:        0001070081
Form:       8-K
Filed at:   2023-07-17T23:59:59+00:00
Accession:  0001070081-23-000040
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PTC Therapeutics appoints Pierre Gravier as CFO effective July 13, 2023
-----------------------------------------------------------------------

- Pierre Gravier, age 38, appointed CFO; previously managing director at Perella Weinberg Partners.
- Annual base salary of $525,000; target annual bonus of 45% of base salary.
- Received inducement equity: 26,000 RSUs (4-year vest) and option for 65,000 shares (4-year vest).
- Severance: 15 months base salary plus health benefits if terminated without cause or for good reason.
- Employment agreement includes perpetual confidentiality, 15-month non-compete/non-solicit.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1070081/000107008123000040/0001070081-23-000040-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1070081/000107008123000040/tmb-20230713x8k.htm
  HTML page:      https://secwatch.observer/filing/0001070081-23-000040

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer